Surgical management of coexisting coronary artery and valvular heart disease

Sak Lee1, Byung-Chul Chang, Kyung-Jong Yoo

  • 1Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, 250 Seongsan-ro, Seodaemun-gu, Seoul 120-752, Korea.

Insights

Combined coronary artery bypass (CAB) and valve surgery is safe and effective. This study shows optimal surgical results and good long-term survival for patients undergoing these complex procedures.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery
  • Thoracic Surgery

Background:

  • Combined coronary artery bypass (CAB) and valve surgery presents significant surgical challenges.
  • Advances in surgical techniques have led to improved outcomes for these complex procedures.

Purpose of the Study:

  • To evaluate the safety and efficacy of combined CAB and valve surgery.
  • To assess the early and long-term outcomes of patients undergoing simultaneous CAB and valve operations.

Main Methods:

  • A retrospective review of 125 patients undergoing combined CAB and valve surgery between 1989 and 2004.
  • Patients underwent simultaneous CAB with valve replacement or repair (mitral, aortic, tricuspid, or double valve).
  • Mean follow-up was 91.4 months.

Main Results:

  • Early mortality was 4.8% (6 patients), primarily due to heart failure and sepsis.
  • Late mortality occurred in 4 patients during the follow-up period.
  • Kaplan-Meier survival rates at 1, 5, and 10 years were 94.4%, 92.3%, and 89.9%, respectively.

Conclusions:

  • Combined CAB and valve operations can be performed safely with optimal surgical results.
  • While surgical mortality is higher than for isolated procedures, long-term survival is not significantly affected.
  • These findings support the safety and effectiveness of combined CAB and valve surgery for appropriate patients.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
274
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
385
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
242
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
237
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
264
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
208